Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Corrigendum: Prognostic significance of FDG PET/CT in esophageal squamous cell carcinoma in the era of the 8th AJCC/UICC staging system.

Author information

Affiliations

  • 1. Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
      Authors
    • Lee H 1
    • Choi JY 1
    (2 authors)
  • 2. Department of Radiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
      Authors
    • Lee KS 2
    (1 author)
  • 3. Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
      Authors
    • Min YW 3
    • Shim YM 3
    (2 authors)
  • 4. Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
      Authors
    • Kim HK 4
    • Zo JI 4
    (2 authors)

Frontiers in Oncology, 28 Oct 2024, 14:1505996
https://doi.org/10.3389/fonc.2024.1505996 PMID: 39529838 

This corrects "Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System." Front Oncol. 2022 Jun 30;12:861867. doi: 10.3389/fonc.2022.861867.

Abstract 

[This corrects the article DOI: 10.3389/fonc.2022.861867.].

Full text links 

Read article at publisher's site: https://doi.org/10.3389/fonc.2024.1505996